- Education
- SIOG Task Forces
- SIOG Working Groups
- Advocacy
- COVID-19 and older patients with cancer
- SIOG Top Priorities Initiative
- SIOG Expert Opinion
- European Cancer Organisation Inequalities Network
- ECPC Cancer Complications and Comorbidities Initiative
- Sanofi Cancer and Ageing
- Sanofi When Cancer Grows Old
- UICC Special Focus Dialogue
- Partnerships in Asia Pacific for Cancer in Ageing
- EU Horizon 2020
SIOG Task Forces
The SIOG Task Forces are active in various fields of geriatric oncology. SIOG Task Forces produce position papers, consensus statements or clinical practice guidelines which then become the official SIOG documents on issues related to cancer in the elderly.
(Description by alphabetical order)
Active Task Forces
- Acute Myeloid Leukemia (AML)
- Corticosteroids and cancer treatments in older patients
- Study to estimate the toxicity, dose-intensity, and benefit of anti-EGFR-based treatment in patients with advanced colon cancer according to age
- Surgical
Completed Task Forces (already published)
- Adherence to oral cancer therapy in older patients
- Anaesthesia in the elderly
- Anti-HER2 targeted treatments in the elderly with breast cancer
- Bisphosphonates in the elderly
- Bone protection in older patients with cancer
- Breast cancer in the elderly
- Chemotherapy toxicity in the elderly
- Chronic Lymphocytic Leukaemia in older patients (CLL)
- Colorectal cancer in the elderly
- Comprehensive Geriatric Assessment (CGA)
- Cultural Competence in the elderly
- Diffuse Large B-Cell Lymphoma in the elderly (DLBCL)
- Impact of nutrition in the management outcomes of older adults with gastrointestinal cancers
- Metastatic renal cell cancer in the elderly
- Oral chemotherapy treatment in the elderly with solid tumours
- Organization of the clinical activity of geriatric oncology
- Quality of life in older cancer patients
- Personalized treatment of elderly patients with rectal cancer
- Prostate cancer in senior adults
- Radiotherapy in the elderly
- Renal safety in the elderly
- Use of antiaromatases (AIs) in the elderly
- (The) management of elderly metastatic Renal Cell Carcinoma (mRCC) patients
- (The) treatment of bladder cancer in older cancer patients
- (The) Use of radiopharmaceuticals in the older patients with cancer
- (The) Use of taxanes in older breast cancer patients
The SIOG Task Forces actively provide the following published materials:
- Newsletters on meeting(s) for the development of the guidelines,
- Abstracts sent to international conferences,
- Presentations in programs of scientific meetings,
- CD Roms with relevant materials
- Monographs on educational topics
- Peer-reviewed published articles on the official SIOG guidelines
NB: Some of the above works have been made possible through unrestricted educational grants from pharmaceutical companies (see each TF for funding details).